Cargando…

Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma

BACKGROUND: The potential of circulating tumour DNA (ctDNA) as a reliable biomarker for relapse/metastasis early detection and prognosis in esophageal squamous cell carcinoma (ESCC) after radiotherapy/chemoradiotherapy (RT/CRT) initiation requires comprehensive investigation. METHODS: Treatment‐naiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin, Yu, Nuo, Cheng, Guowei, Zhang, Tao, Wang, Jianyang, Deng, Lei, Li, Jiao, Zhao, Xiaotian, Xu, Yang, Yang, Peng, Bai, Na, Li, Yin, Bi, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702363/ https://www.ncbi.nlm.nih.gov/pubmed/36437506 http://dx.doi.org/10.1002/ctm2.1116

Ejemplares similares

Intensity modulated radiotherapy might be effective for locally advanced esophageal carcinosarcoma: A single center’s experience and review of literature
por: Yang, Siran, et al.
Publicado: (2022)

Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database
por: Yu, Jing, et al.
Publicado: (2018)

Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma
por: Dong, Qianze, et al.
Publicado: (2017)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
por: Xiang, Yongbo, et al.
Publicado: (2023)

The prognostic value of pre-treatment prognostic nutritional index in esophageal squamous cell carcinoma: A meta-analysis
por: Li, Pengfei, et al.
Publicado: (2019)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
por: An, Lingbo, et al.
Publicado: (2023)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy
por: Xiao, Ling, et al.
Publicado: (2022)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis
por: Li, Chen, et al.
Publicado: (2021)

Transcriptome alteration spectrum in rat lung induced by radiotherapy
por: Zhang, Tao, et al.
Publicado: (2019)

Remission of pulmonary alveolar proteinosis after radiotherapy in a patient with comorbid small cell lung cancer
por: Xiang, Yongbo, et al.
Publicado: (2023)

Association of radiotherapy with thoracic vertebral fractures in esophageal squamous cell carcinoma: A retrospective cohort study
por: Wu, Xing-Qiang, et al.
Publicado: (2023)

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
por: Wu, Xiaoyue, et al.
Publicado: (2022)

Evaluation of Automatic Segmentation Model With Dosimetric Metrics for Radiotherapy of Esophageal Cancer
por: Zhu, Ji, et al.
Publicado: (2020)

Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer
por: Lv, Yajuan, et al.
Publicado: (2020)

A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy
por: Zhang, Fang, et al.
Publicado: (2013)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
por: Xu, Nana, et al.
Publicado: (2021)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

Characterization of plasma exosomal microRNAs in responding to radiotherapy of human esophageal squamous cell carcinoma
por: Miao, Nan, et al.
Publicado: (2022)

A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma
por: Zhang, Fang, et al.
Publicado: (2014)

Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma
por: Chen, Hongmin, et al.
Publicado: (2018)

Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy
por: Liao, Xiu-Yong, et al.
Publicado: (2019)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2020)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy
por: Qiu, Jianjian, et al.
Publicado: (2023)

Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
por: Chen, Weipeng, et al.
Publicado: (2018)

The Geriatric Nutritional Risk Index Predicts Survival in Elderly Esophageal Squamous Cell Carcinoma Patients with Radiotherapy
por: Bo, Yacong, et al.
Publicado: (2016)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
por: Yanagita, Takumi, et al.
Publicado: (2023)

Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma
por: Yang, Dongyang, et al.
Publicado: (2022)

Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial
por: Yang, Xu, et al.
Publicado: (2021)

The Spatial Predilection for Early Esophageal Squamous Cell Neoplasia: A “Hot Zone” for Endoscopic Screening and Surveillance
por: Wang, Wen-Lun, et al.
Publicado: (2016)

Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy
por: Li, Zhenjiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36ivfdamrmqp01fvb8rfr4g8ug